Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

24.10EUR
17 May 2019
Change (% chg)

€0.31 (+1.30%)
Prev Close
€23.79
Open
€23.86
Day's High
€24.10
Day's Low
€23.59
Volume
708,238
Avg. Vol
648,198
52-wk High
€28.07
52-wk Low
€21.57

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.59
Market Cap(Mil.): €14,630.30
Shares Outstanding(Mil.): 687.55
Dividend: 0.20
Yield (%): 1.25

Financials

  GRLS.MC Industry Sector
P/E (TTM): 29.01 54.03 55.51
EPS (TTM): 0.83 -- --
ROI: 5.23 11.89 11.59
ROE: 14.00 13.19 16.33

Spain's Grifols, China's Shanghai RAAS form strategic alliance

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

Mar 07 2019

Spain's Grifols, China's Shanghai RAAS form strategic alliance

March 7 Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

Mar 07 2019

Earnings vs. Estimates